The global intravenous solutions market is anticipated to grow at a considerable CAGR of 8.7% during the forecast period (2022-2028). The increasing number of surgeries and increasing number of cancer cases is boosting the global intravenous solutions market. According to American college of surgeons (ACS), around 15 million Americans have some kind of surgery. Furthermore according to WHO,
• Cancer is a leading cause of death across the globe, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.
• Around one-third of deaths from cancer are due to tobacco use, high body mass index,
• In 2020, most common cancer were breast (2.26 million cases), lung (2.21 million cases), colon and rectum (1.93 million cases), prostate (1.41 million cases), skin (non-melanoma) (1.20 million cases), and stomach (1.09 million cases).
Browse the full report description of “Intravenous Solutions Market Size, Share & Trends Analysis Report by Product (Total Parenteral Nutrition, and Peripheral Parenteral Nutrition), and by Nutrients (Carbohydrates, Vitamins and Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/intravenous-solutions-market
The most common causes of cancer death in 2020 were, lung (1.80 million deaths), colon and rectum (916 000 deaths), liver (830 000 deaths), stomach (769 000 deaths), and breast (685 000 deaths). Each year, around 400,000 children develop cancer, due to these rising cases of cancer and surgeries across the globe, the intravenous solution demand will increases as it will be used by hospitals , doctors on the patients during and after the treatment and surgery, because these solutions are used to provide essential nutrients and dehydrate the body to recover the body fast as many cancers leave patients prone to dehydration. These decreases in electrolytes and physiological fluid can severely impair cells of the body. For this reason, Intravenous nutrients and electrolytes are delivered via IV Therapy which quickly hydrates the body.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By Nutrients
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols International, S.A., ICU Medical, Inc. ,and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Intravenous Solutions Market Report Segment
By Product
By Nutrients
Global Intravenous Solutions Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/intravenous-solutions-market